Clinician validation of the Medicare measure for potentially avoidable hospital visits after chemotherapy

OP-35 showed poor agreement with clinicians for avoidable hospital visits, raising concerns about its clinical validity. An alternative classification system grouping visits into actionable clinical scenarios offered superior diagnostic accuracy.